Thursday, 21 November 2024
A world-class impact accelerator will connect hundreds of East Midlands MedTech SMEs with health and care professionals, academics and the public to drive the design, development and delivery of pioneering rehabilitation technologies.
The ‘EMERGE’ project – East Midlands Emerging RehabTech Growth Enterprise – will launch the East Midlands as the UK’s ‘RehabTech Valley’, a leading hub for rehabilitation technologies excellence.
Nottingham Trent University has been awarded £2.5 million by the UKRI Engineering and Physical Sciences Research Council to lead the project, which is expected to accelerate innovation into health and care pathways and transform how people recover and regain independence and function following injury or illness.
The 糖心原创, Loughborough University and the University of Derby will co-lead, supported by a 30-strong consortium spanning research and innovation, medical and health tech organisations, the NHS, local government and economic development.
As people live longer and chronic health conditions increase, the demand for rehabilitation technologies, or ‘RehabTech’, is soaring.
The project will connect the region’s cluster of 459 med-tech SMEs, addressing current challenges around slowing productivity, access to skills, clinical partnerships and private investment.
It will create mechanisms for engagement between businesses, academics, the NHS and patients and speed up the development and availability of RehabTech. It will translate theoretical breakthroughs and proof-of-concept ideas to cutting-edge innovations across areas including sensors and imaging, medical device materials and device design, smart medical wearables, bioengineering, robotics and artificial intelligence.
As well as supporting recovery and helping people to regain their independence, the move is expected to deliver a significant economic impact, boosting regional growth and productivity and enabling SMEs to secure an increasing share of a rapidly growing market.
Work will also involve ensuring public and patient involvement is embedded in activities and projects to best address health inequalities. There are widening health inequalities in the East Midlands and preventable diseases such as heart disease, stroke and chronic obstructive pulmonary disease are worse in the region’s cities than the UK average.
The EMERGE project will be led from Nottingham Trent University’s Medical Technologies Innovation Facility, a dual-site medical devices and advanced materials technology innovation centre.
Professor Richard Emes, Pro Vice-Chancellor Research and International at Nottingham Trent University, said: “This award further supports our ambitions in the theme of Health Innovation where NTU researchers are dedicated to transforming patient and community care outcomes.
“The impact acceleration account will speed the translation of applied research between academic partners and healthcare providers in the region to achieve real-world change for the benefit of patients.”
We look forward to working with our regional partners to create new Rehabilitation Technologies that will benefit patients and businesses.鈥�
Seven projects are being funded through EPSRC’s Place Based Impact Acceleration Account (PBIAA) scheme. EPSRC Executive Chair, Professor Charlotte Deane, said: “The seven projects announced today will harness regional research and innovation strengths to unleash the potential of emerging and existing innovation clusters across the UK.
“Our investment will strengthen partnerships between UK universities, civic bodies and local businesses to create new jobs, improve skills and boost regional economic growth that will benefit places and communities directly.”
Story credits
More information is available from Faith Pring on faith.pring@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.